Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries.

Fuller DS, Hallett D, Dluzniewski PJ, Fouqueray B, Jadoul M, Morgenstern H, Port FK, Tentori F, Pisoni RL.

BMC Nephrol. 2019 May 14;20(1):169. doi: 10.1186/s12882-019-1355-5.

2.

Clinical Pharmacokinetics and Pharmacodynamics of Etelcalcetide, a Novel Calcimimetic for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis.

Wu B, Melhem M, Subramanian R, Chen P, Jaramilla Sloey B, Fouqueray B, Hock MB, Skiles GL, Chow AT, Lee E.

J Clin Pharmacol. 2018 Jun;58(6):717-726. doi: 10.1002/jcph.1090. Epub 2018 Mar 13. Review.

PMID:
29534286
3.

[Cinacalcet impact on calcium homeostasis and bone remodeling in 13 renal transplanted patients with hyperparathyroidism and hypercalcaemia].

Boulanger H, Haymann JP, Fouqueray B, Mansouri R, Metivier F, Mercadal L, Attaf D, Flamant M, Glotz D.

Nephrol Ther. 2012 Feb;8(1):47-53. doi: 10.1016/j.nephro.2011.04.007. Epub 2011 Jun 23. French. Erratum in: Nephrol Ther. 2012 Apr;8(2):126-7.

PMID:
21703956
4.

An epidemiological study of hemodialysis patients based on the European Fresenius Medical Care hemodialysis network: results of the ARO study.

de Francisco AL, Kim J, Anker SD, Belozeroff V, Canaud B, Chazot C, Drüeke TB, Eckardt KU, Floege J, Kronenberg F, Macdougall IC, Marcelli D, Molemans B, Passlick-Deetjen J, Schernthaner G, Stenvinkel P, Wheeler DC, Fouqueray B, Aljama P.

Nephron Clin Pract. 2011;118(2):c143-54. doi: 10.1159/000319936. Epub 2010 Dec 10.

5.

Hemoglobin variability does not predict mortality in European hemodialysis patients.

Eckardt KU, Kim J, Kronenberg F, Aljama P, Anker SD, Canaud B, Molemans B, Stenvinkel P, Schernthaner G, Ireland E, Fouqueray B, Macdougall IC.

J Am Soc Nephrol. 2010 Oct;21(10):1765-75. doi: 10.1681/ASN.2009101017. Epub 2010 Aug 26.

6.

Autoimmune hypoparathyroidism associated with pulmonary tuberculosis.

Bachmeyer C, Fouqueray B, Fabien N, Cadranel J, Haymann JP.

QJM. 2011 May;104(5):441-3. doi: 10.1093/qjmed/hcq109. Epub 2010 Jul 6. No abstract available.

PMID:
20605844
7.

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.

Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC; ARO Investigators.

Nephrol Dial Transplant. 2011 Jun;26(6):1948-55. doi: 10.1093/ndt/gfq219. Epub 2010 Apr 25.

8.

Timing of onset of CKD-related metabolic complications.

Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, M'rad MB, Jacquot C, Houillier P, Stengel B, Fouqueray B; NephroTest Study Group.

J Am Soc Nephrol. 2009 Jan;20(1):164-71. doi: 10.1681/ASN.2008020159. Epub 2008 Nov 12.

9.

Pitfalls of measuring total blood calcium in patients with CKD.

Gauci C, Moranne O, Fouqueray B, de la Faille R, Maruani G, Haymann JP, Jacquot C, Boffa JJ, Flamant M, Rossert J, Urena P, Stengel B, Souberbielle JC, Froissart M, Houillier P; NephroTest Study Group.

J Am Soc Nephrol. 2008 Aug;19(8):1592-8. doi: 10.1681/ASN.2007040449. Epub 2008 Apr 9.

10.

Partial fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate loss.

François H, Coppo P, Hayman JP, Fouqueray B, Mougenot B, Ronco P.

Am J Kidney Dis. 2008 Feb;51(2):298-301. doi: 10.1053/j.ajkd.2007.10.039.

PMID:
18215707
11.

The ESCI Award for Excellence in Clinical Science 2006.

Fouqueray B.

Eur J Clin Invest. 2007 Apr;37(4):235. No abstract available.

PMID:
17373957
12.

[Biology of renal functions and renal insufficiency].

Cristol JP; Biologie des Fonctions Rénales et de l'Insuffisance Rénale; Société Française de Biologie Clinique, Seronie-Vivien S, Sternberg M, Cavalier E, Blanchecotte F, Hanser AM, Pieroni L, Galteau MM, Monge M, Boutten A, Desch G, Ait Djafer Z, Carlier MC, Barguil Y, Terrier N, Guerber F, Souberbielle JC, Delmas Y, Delanaye P, Panescu V, Rossert J, Fouqueray B, Houillier P, Froissart M, Lefebvre HP, Canaud B, Halimi JM.

Ann Biol Clin (Paris). 2006 Nov-Dec;64(6):608-11. French. No abstract available.

13.

Effect of early correction of anemia on the progression of CKD.

Rossert J, Levin A, Roger SD, Hörl WH, Fouqueray B, Gassmann-Mayer C, Frei D, McClellan WM.

Am J Kidney Dis. 2006 May;47(5):738-50.

PMID:
16632012
14.

[Contribution of stem cells to renal repair after ischemia/reperfusion].

Baud L, Haymann JP, Bellocq A, Fouqueray B.

Bull Acad Natl Med. 2005 Apr;189(4):635-43; discussion 643-4. Review. French.

PMID:
16245682
15.

Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia.

Boulanger H, Haymann JP, Fouqueray B, Mansouri R, Metivier F, Sarfati E, Glotz D.

Nephrol Dial Transplant. 2005 Dec;20(12):2865. Epub 2005 Aug 22. No abstract available.

PMID:
16115841
16.

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.

Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, Henquell C, Abergel A, Pawlotsky JM, Hezode C, Coudé M, Blanchi A, Alain S, Loustaud-Ratti V, Chevallier P, Trepo C, Gerolami V, Portal I, Halfon P, Bourlière M, Bogard M, Plouvier E, Laffont C, Agius G, Silvain C, Brodard V, Thiefin G, Buffet-Janvresse C, Riachi G, Grattard F, Bourlet T, Stoll-Keller F, Doffoel M, Izopet J, Barange K, Martinot-Peignoux M, Branger M, Rosenberg A, Sogni P, Chaix ML, Pol S, Thibault V, Opolon P, Charrois A, Serfaty L, Fouqueray B, Grange JD, Lefrère JJ, Lunel-Fabiani F.

J Viral Hepat. 2005 Jul;12(4):405-13.

PMID:
15985012
17.

Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.

Letavernier E, Perez J, Joye E, Bellocq A, Fouqueray B, Haymann JP, Heudes D, Wahli W, Desvergne B, Baud L.

J Am Soc Nephrol. 2005 Aug;16(8):2395-402. Epub 2005 Jun 8.

18.
19.

Screening and management of patients with early chronic kidney disease.

Rossert J, Fouqueray B.

Acta Diabetol. 2004 Mar;41 Suppl 1:S6-12. Review.

PMID:
15103542
20.

[Calpains participate in inflammatory reaction development].

Baud L, Fouqueray B, Bellocq A, Peltier J.

Med Sci (Paris). 2003 Jan;19(1):71-6. Review. French.

21.

Anemia management and the delay of chronic renal failure progression.

Rossert J, Fouqueray B, Boffa JJ.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S173-7. Review.

22.
23.

[Inflammation, prelude to renal sclerosis: the importance of NF-kappa B].

Baud L, Fouqueray B, Bellocq A, Haymann JP, Peltier J.

J Soc Biol. 2002;196(4):269-73. Review. French.

PMID:
12645294
24.

Fanconi syndrome and renal failure induced by tenofovir: a first case report.

Verhelst D, Monge M, Meynard JL, Fouqueray B, Mougenot B, Girard PM, Ronco P, Rossert J.

Am J Kidney Dis. 2002 Dec;40(6):1331-3.

PMID:
12460055
25.

Recovery of plasma volume after 1 week of exposure at 4,350 m.

Robach P, Lafforgue E, Olsen NV, Déchaux M, Fouqueray B, Westerterp-Plantenga M, Westerterp K, Richalet JP.

Pflugers Arch. 2002 Sep;444(6):821-8. Epub 2002 Aug 2.

PMID:
12355184
26.

Induction of urokinase receptor expression in nephrotoxic nephritis.

Xu Y, Berrou J, Chen X, Fouqueray B, Callard P, Sraer JD, Rondeau E.

Exp Nephrol. 2001;9(6):397-404.

PMID:
11701999
27.

Repair of glomerular inflammation.

Baud L, Fouqueray B, Bellocq A, Doublier S, Peltier J.

Adv Nephrol Necker Hosp. 2001;31:243-56. Review. No abstract available.

PMID:
11692463
28.

Haemodynamic changes and vasopressin release are not consistently associated with carbon dioxide pneumoperitoneum in humans.

Lentschener C, Axler O, Fernandez H, Megarbane B, Billard V, Fouqueray B, Landault C, Benhamou D.

Acta Anaesthesiol Scand. 2001 May;45(5):527-35.

PMID:
11308999
29.

Transforming growth factor-beta inhibits interleukin-10 synthesis by human monocytic cells.

Suberville S, Bellocq A, Peguillet I, Lantz O, Stordeur P, Fouqueray B, Baud L.

Eur Cytokine Netw. 2001 Mar;12(1):141-6.

30.

Cytokines and hormones with anti-inflammatory effects: new tools for therapeutic intervention.

Baud L, Fouqueray B, Bellocq A.

Curr Opin Nephrol Hypertens. 2001 Jan;10(1):49-54. Review.

PMID:
11195051
31.

Nephrotoxic nephritis and obstructive nephropathy: evaluation with MR imaging enhanced with ultrasmall superparamagnetic iron oxide-preliminary findings in a rat model.

Hauger O, Delalande C, Deminière C, Fouqueray B, Ohayon C, Garcia S, Trillaud H, Combe C, Grenier N.

Radiology. 2000 Dec;217(3):819-26.

PMID:
11110949
32.

Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1.

Doublier S, Seurin D, Fouqueray B, Verpont MC, Callard P, Striker LJ, Striker GE, Binoux M, Baud L.

Kidney Int. 2000 Jun;57(6):2299-307.

33.

[Interactions between glucocorticoids and anti-inflammatory peptides].

Bellocq A, Doublier S, Peltier J, Suberville S, Fouqueray B, Baud L.

J Soc Biol. 1999;193(4-5):381-3. Review. French.

PMID:
10689621
34.

Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP.

Martinot-Peignoux M, Roudot-Thoraval F, Mendel I, Coste J, Izopet J, Duverlie G, Payan C, Pawlotsky JM, Defer C, Bogard M, Gerolami V, Halfon P, Buisson Y, Fouqueray B, Loiseau P, Lamoril J, Lefrere JJ, Marcellin P.

J Viral Hepat. 1999 Nov;6(6):435-43.

PMID:
10607261
35.

Somatostatin increases glucocorticoid binding and signaling in macrophages by blocking the calpain-specific cleavage of Hsp 90.

Bellocq A, Doublier S, Suberville S, Perez J, Escoubet B, Fouqueray B, Puyol DR, Baud L.

J Biol Chem. 1999 Dec 24;274(52):36891-6.

36.

Haemodynamic changes associated with portal triad clamping are suppressed by prior hepatic pedicle infiltration with lidocaine in humans.

Lentschener C, Franco D, Bouaziz H, Mercier FJ, Fouqueray B, Landault C, Mazoit JX, Benhamou D.

Br J Anaesth. 1999 May;82(5):691-7.

37.

Renin-angiotensin system inhibition in a patient having an overdose of HIV protease inhibitor.

Duval X, Peytavin G, Fouqueray B, Leport C, Vildé JL.

AIDS. 1999 Oct 1;13(14):1983-4. No abstract available.

PMID:
10513662
38.

Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms.

Bellocq A, Azoulay E, Marullo S, Flahault A, Fouqueray B, Philippe C, Cadranel J, Baud L.

Am J Respir Cell Mol Biol. 1999 Jul;21(1):128-36.

PMID:
10385601
39.

[Inflammatory mechanisms of renal fibrosis: glomerulonephritis].

Baud L, Fouqueray B, Bellocq A.

Bull Acad Natl Med. 1999;183(1):23-31. Review. French.

PMID:
10371762
40.

Growth hormone and somatostatin in glomerular injury.

Baud L, Fouqueray B, Bellocq A, Doublier S, Dumoulin A.

J Nephrol. 1999 Jan-Feb;12(1):18-23. Review.

PMID:
10202998
41.
42.

[Polyuropolydipsic syndromes].

Fouqueray B, Paillard F, Baud L.

Presse Med. 1998 Oct 10;27(30):1545-53. Review. French.

PMID:
9810314
43.

Switching off renal inflammation by anti-inflammatory mediators: the facts, the promise and the hope.

Baud L, Fouqueray B, Bellocq A.

Kidney Int. 1998 May;53(5):1118-26. Review. No abstract available.

44.

Interleukin 10: a logical candidate for suppressing glomerular inflammation?

Baud L, Fouqueray B, Suberville S, Doublier S.

Exp Nephrol. 1998 Jan-Feb;6(1):22-7. Review.

PMID:
9523170
45.

Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages. Evidence for involvement of nuclear factor-kappaB activation.

Bellocq A, Suberville S, Philippe C, Bertrand F, Perez J, Fouqueray B, Cherqui G, Baud L.

J Biol Chem. 1998 Feb 27;273(9):5086-92.

46.

Insulin-like growth factors and their binding proteins in pleural fluid.

Le Bouc Y, Bellocq A, Philippe C, Perin L, Garabedian M, Fouqueray B, Zacharias C, Cadranel J, Baud L.

Eur J Endocrinol. 1997 Nov;137(5):467-73.

PMID:
9405025
47.

[Low extracellular pH has a role in the induction of NO synthase type 2 in macrophages].

Baud L, Bellocq A, Philippe C, Fouqueray B.

Bull Acad Natl Med. 1997 Feb;181(2):247-58; discussion 259-60. French.

PMID:
9235225
48.

Regulation of interleukin-10 production by beta-adrenergic agonists.

Suberville S, Bellocq A, Fouqueray B, Philippe C, Lantz O, Perez J, Baud L.

Eur J Immunol. 1996 Nov;26(11):2601-5.

PMID:
8921945
49.

Characterization of insulin-like growth factor binding proteins and regulation of IGFBP3 in human mesangial cells.

Grellier P, Sabbah M, Fouqueray B, Woodruff K, Yee D, Abboud HE, Abboud SL.

Kidney Int. 1996 Apr;49(4):1071-8.

50.

Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells.

Wenzel UO, Fouqueray B, Grandaliano G, Kim YS, Karamitsos C, Valente AJ, Abboud HE.

Circ Res. 1995 Sep;77(3):503-9.

PMID:
7641321

Supplemental Content

Loading ...
Support Center